MNOV Key Stats
- Nasdaq stocks posting largest volume increases May 15
- Monday Sector Leaders: Biotechnology, Drugs May 13
- Morning Market Movers Benzinga May 13
- MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, U... May 9
- MEDICINOVA INC Files SEC form 8-K, Regulation FD Disclosure May 9
- Medicinova, Inc. (MNOV) Posts Q1 Loss of 14c/Share Street Insider May 8
- MediciNova Reports First Quarter 2013 Results GlobeNewswire May 8
- MEDICINOVA INC Files SEC form 10-Q, Quarterly Report May 8
- MedicNova enters into 6M equity distribution agreement with Macquarie Apr 18
- MEDICINOVA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, F... Apr 17
MNOV Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). MediciNova is up 4.23% over the last year vs S&P 500 Total Return up 31.95%, Arrowhead Research Corporation down 48.46%, and ARCA biopharma down 5.73%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Pro Ratings for MNOV
Pro Report PDF for MNOV
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download MNOV Pro Report PDF
Pro Strategies Featuring MNOV
Did MediciNova make it into our Pro Portfolio Strategies?